In addition, Lehman et al. revealed that AKT3 promotes the survival of inflammatory BC (IBC, the deadliest form of BC) cells, but has no effect on the invasion of IBC or non-IBC cell lines [51]. Here, AKT3 is linked to inflammatory breast carcinoma.